15054 Impact of baricitinib on patient-reported skin symptoms, itch, and quality of life in adult patients with moderate to severe atopic dermatitis and an inadequate response to topical therapies from phase 3 trials BREEZE-AD1 and BREEZE-AD2
Lio, Peter, Nosbaum, Audrey, Cardillo, Tracy, DeLozier, Amy, Gamalo, Margaret, Ball, Susan G., Bieber, ThomasVolume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.198
Date:
December, 2020
File:
PDF, 820 KB
2020